CD274 and neoplasm: Recently, miR-195 and miR-497 were found to downregulate the cluster of differentiation CD274 (also known as PD-L1) in triple negative breast cancer cells, suggesting that miR-195/miR-497 influence tumor progression, inhibit the immune response and promote tumor immune escape [53] (Figure 1).